Amylin leads drug stocks lower
Marketwatch 8/19/08

Byetta woes threaten wider diabetes drug class
Guardian, UK 8/19/08

Merck Vioxx study was for marketing: researchers
Reuters 8/19/08

Novo Nordisk Expects Stronger Warning Requirements From FDA
Bloomberg 8/19/08

Replenishing The Pipeline: And The Winner Is…
Pharmalot 8/19/08

King Pharma says Remoxy pain drug Phase III successful
Marketwatch 8/19/08

Anatomy of The Amylin Drug Warning
CNBC 8/19/08

Johnson & Johnson: The Type of Growth Stock I Favor
Seeking Alpha 8/19/08

[video]Street Insider: Pharma
CNBC 8/19/08

Some Biotechs Get a Bounce
Barrons 8/19/08

Would Genentech Be Better Off Left Alone by Roche?
Seeking Alpha 8/19/08

Johnson & Johnson's New High
Seeking Alpha 8/19/08

Biotech ETFs: Can You Handle 209% Volatility?
Seeking Alpha 8/19/08

Genentech and Roche, Act Two
In the Pipeline 8/19/08

AstraZeneca Gives FluMist Spray a Shot in the Arm
Seeking Alpha 8/19/08

Biotech: When Breaking Up Isn't Hard to Do
Motley Fool 8/19/08

Vertex, J&J to Begin New Telaprevir Study
TheStreet.com 8/19/08

Vertex to begin expanded trial for hepatitis drug
Bizjournals.com 8/19/08

Dyax Gains With Test Results
Forbes 8/19/08

Cell Therapeutics Q2 loss: $59M
Bizjournals.com 8/19/08

Medtronic expected to show lower operating costs, higher sales of stents in first quarter
Yahoo/AP 8/19/08

Allergan: When Deals Get Ugly
SeekingAlpha 8/18/08

Drug stocks edge higher, while Dyax rockets
Marketwatch 8/18/08

Time to Invest in Pharmaceuticals?
SeekingAlpha 8/18/08

Browsing in the Biotech Aisle
Barron's 8/18/08

Sales Reps, Doctors & ‘Emotional Connections’
Pharmalot 8/18/08

New England Journal Editors File Brief Against Wyeth
Bloomberg 8/18/08

For Bristol, steady course may be best navigation
Guardian/Reuters 8/18/08

Roche Sues Drugmakers to Block Generic Boniva Osteoporosis Drug
Bloomberg 8/18/08

Roche sells four products to Meda
Hays Pharma 8/18/08

Schering-Plough Expands Its Presence In China, Enters Next Stage Of Development
Pharmaceutical Online 8/18/08

Enzon Pharma Risks Balanced
Yahoo/Zacks.com 8/18/08

For Cubist, a tough sell
Boston Globe, MA 8/18/08

Texas Suspends Psych Drug Program For Kids
Pharmalot 8/18/08

J&J Wins Favored Status
By Curing Statue Fungus Woes
WSJ Online 8/18/08

Ardea Biosciences Still Developing
Yahoo/Zacks.com 8/18/08

5 Potential Buyout Targets in Biotech - Barron's
Seeking Alpha 8/17/08

Four Drug Companies Vying for Diabetes Patients
Seeking Alpha 8/17/08

Teva's accounting exercise
Globes, Isreal 8/17/08

Drug chief hits back at pharmaceutical firms (in the UK)
inthenews.co.uk, United Kingdom 8/17/08

Recruiters eye Genentech employees
San Francisco Chronicle, CA 8/17/08

Genentech Pipeline: Too Good To Settle for Less?
Seeking Alpha 8/16/08

Report: Analysts peg Genentech price at $107.50 a share
Bizjournals 8/16/08

Biotech-Stock Mailbag: Genentech
The Street 8/16/08

Drug stocks mixed; Elan continues rebound
MarketWatch 8/16/08

Tongjitang Chinese Medicine: Earnings Up, But Counterfeits Hurt Sales
Seking Alpha 8/16/08

WuXi: Solid Earnings, Solid Outlook
Seking Alpha 8/16/08

Significant Reduction In Rate Of Lung Function Decline Achieved In COPD Patients Receiving Seretide®/Advair®
Medical News Today 8/16/08

Dendreon Risk: Delays with Provenge
Yahoo/Zacks 8/16/08

Sun Pharma announces US FTC clearance for Taro tender offer
Trading Markets 8/16/08

Drug Company Comes In A Day Late, But Not A Dollar Short
Yahoo/Investor's Business Daily 8/16/08

Catalyst Pharmaceutical Q2 losses nearly double
Triangle Business Journal, NC 8/16/08

Accentia Biopharmaceuticals sees Q3 loss narrow, receives Nasdaq notice
Bizjournals 8/16/08

NUCRYST Receives Deficiency Notice from NASDAQ
CNW Telbec, Canada 8/16/08

AMDL Q2 Net Loss Narrows On 140% Revenue Growth
RTT News 8/16/08

FDA approves 1st drug for Huntington's disease
Newsday 8/16/08

Personalized Immunotherapy To Fight HIV/AIDS
Science Daily 8/16/08

MethylGene Provides Update on Suspension of New Enrollment in MGCD0103 Clinical Trials
Genetic Engineering News 8/16/08

Spectrum Pharmaceuticals Launches FUSILEV(TM)
Yahoo 8/16/08

Drug Ads Losing Recall Effectiveness Among Consumers
BrandWeek 8/16/08

Pharma donors favor Obama
Medical Marketing and Media 8/16/08

Gen-Probe blood assay gets FDA approval for hepatitis B
SmartBrief 8/16/08

Abbott and AstraZeneca to co-market Crestor
Yahoo/AP 8/14/08

Schering Drug Derailed by Power of One
TheStreet.com 8/14/08

Genentech says 'no' to Roche
Trading Markets 8/14/08

Schering Regroups After FDA Rejection
TheStreet.com 8/14/08

Updates on the Healthcare/Biotech Mergers
Seeking Alpha 8/14/08

Elan to Reward Investors Braving MS Drug's Brain Risk
Bloomberg 8/14/08

Novartis MS drug may work against viral infection: study
Reuters 8/14/08

Schering-Plough Takes Sole Possession of Its China JV
SeekingAlpha 8/14/08

Wyeth extends atherosclerosis partnership
Yahoo/AP 8/14/08

Physicians Expect to Shift More Time to Online Professional Resources in the Coming Years
Trading Markets 8/14/08

SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
PR Newswire 8/14/08

Indevus Pharmaceuticals says overactive bladder treatment gets patent protection through 2025
Yahoo/AP 8/14/08

Stents, Drugs or Both: Debate May Get New Life
CNBC 8/14/08

FDA approves Gilead's Viread for chronic hepatitis B treatment in adults
Pharmaceutical Business Review 8/14/08

Lilly helps fund MS drug trial
Chronicle-Herald, Canada 8/14/08

WuXi PharmaTech Earnings Seem Stellar
SeekingAlpha 8/14/08

FTC Challenges Sun Pharmaceuticals' Purchase of Taro Pharmaceutical Industries
Trading Markets 8/14/08

Cardiome and Astellas receive FDA approvable letter for Kynapid injection
Pharmaceutical Business Review 8/14/08

Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
Yahoo 8/14/08

Strict Law to Curb Physician Gifts
PharmExec 8/13/08

CSL to Buy Talecris for $3.1 Billion in Record Buyout
Bloomberg 8/13/08

Is Big Pharma Finally Back?
CNBC 8/13/08

Pharma sales to physicians: emotions beat evidence
Fierce Pharma 8/13/08

Bids for embattled Elan arm pitch value of unit at $1.4bn
Irish Independent 8/13/08

Are Big Pharma's Dollar Days Nearly Over?
Seeking Alpha 8/13/08

Lilly would bolster pipeline
Indianapolis Star, IN 8/13/08

Pharmaceutical giants tracking Mylan's prosperity
Pittsburgh Tribune Review, PA 8/13/08

My Model Biotech Picks: What's Hot and What's Not
Seeking Alpha 8/13/08

Dendreon Earnings Stay Put
Forbes 8/13/08

Dendreon Banks On October
Forbes 8/13/08

FDA warns of skin reactions seen with injectable alcoholism treatment from Cephalon, Alkermes
Yahoo/AP 8/13/08

Ranbaxy Drugs Win Approval Amid Probe Whether Data Were False
Bloomberg 8/13/08

ANALYSIS-New US drug rulings may confuse investors
Forbes 8/13/08

Cramer's Latest Biotech Buy
CNBC 8/13/08

Don't Discard Omrix
Motley Fool 8/13/08

The FDA Stands Up Cardiome
Motley Fool 8/13/08

Biovail Has Loss in Second Quarter; Revenue Declines
Bloomberg 8/13/08

Altus Shares Plummet on Drug Trial
TheStreet.com 8/13/08

Lundbeck Profit Drops After Alzheimer Drug Failure
Bloomberg 8/13/08

Anesiva: Painless Going Forward?
Yahoo/Zacks.com 8/13/08

[video]Cramer: Bristol's Bid to Beat Cancer
CNBC 8/12/08

Pfizer Breaks A Barrier
CNBC 8/12/08

Pfizer to lose top spot by 2014
InPharmaTechnologist 8/12/08

Big Pharma’s Healthy Appetite for Acquisitions
Seeking Alpha 8/12/08

By How Much Will Roche Increase Its Valuation for Genentech?
Seeking Alpha 8/12/08

Drugmakers: We Couldn’t Guess How Much Those Lawsuits Might Cost
WSJ Online 8/12/08

Icahn Increases Biogen Idec Stake to 6.03 Percent
Bloomberg 8/12/08

Elan seeks fast sale of drug delivery unit-sources
Guardian, UK 8/12/08

Enzon's Split Ends
Forbes 8/12/08

Pain Therapeutics, King drug gets priority review
Yahoo/AP 8/12/08

Sanofi-Aventis Sues Apotex Over Taxotere US Patents
Easy Bourse, France 8/12/08

Schering-Plough Expands Its Presence in China, Enters Next Stage of Development
PharmaLive 8/12/08

Drugmakers protest plan on legal costs: report
Boston Globe, MA 8/12/08

J&J unit Ethicon Endo-Surgery to buy SurgRx
Yahoo/AP 8/12/08

Enzon co-founder returns with new biotech
Star Ledger, NJ 8/12/08

FDA approves Gilead's Viread for hepatitis treatment
bizjournals.com 8/12/08

Dynavax and Merck Announce Phase 3 Trial with Investigational Hepatitis B Vaccine Met its Primary Endpoint
Admet 8/12/08

PDL BioPharma Q2 profit jumps to $33.9M
bizjournals.com 8/12/08

Bristol-Myers and ImClone Tussle Over Follow-Up to Erbitux
WSJ Online 8/11/08

Will Roche Go "Crazy" For Genentech?
CNBC 8/11/08

Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity
Seeking Alpha 8/11/08

Bayer’s high hopes for new drug that prevents blood clots
The Post, Ireland 8/11/08

Johnson & Johnson Profit-Taking Likely, Offering Better Entry Point
Seeking Alpha 8/11/08

Just What the Doctor Ordered: Healthcare and Biotech ETF Review
Seeking Alpha 8/11/08

China Biotech Week in Review: Earnings and More
Seeking Alpha 8/11/08

Daiichi Sankyo to Begin Ranbaxy Tender on Aug. 16
Bloomberg 8/11/08

Valeant posts 2nd-quarter loss on lower sales and higher taxes, but shares hit year high
Yahoo/AP 8/11/08

Heath Ledger's Legacy For Drug Marketers
Brandweek 8/11/08

Inspire Pharmaceuticals tops Wall Street sales estimates
bizjournals.com 8/11/08

Clarient: Clearly a Winner
Seeking Alpha 8/11/08

Ready for Dr. Reddy's Labs
Seeking Alpha 8/11/08

Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)
Yahoo 8/11/08

Drug companies kicking up prices on rarer treatments
InForum 8/11/08

Alnylam Pharma Seeks Alliances
Yahoo/Zacks.com 8/11/08

Enzon Explores Selling Off Single Drugs, or Division
Bloomberg 8/11/08

Determined Elan stands by Tysabri drug despite market worries
Westmeath Independant, Ireland 8/10/08

Phase 3 Trial With Investigational Hepatitis B Vaccine (HEPLISAV) Met Primary Endpoint
Medical News Today 8/10/08

Lilly taps hedge fund
Indianapolis Business Journal 8/9/08

Biotech Stocks Regain Some Lost Ground
The Street 8/9/08

Somaxon Drug Awaits Approval
Trading Markets 8/9/08

BRIDION(R) (sugammadex) Injection - First And Only Selective Relaxant Binding Agent - Approved In European Union
Medical News Today 8/9/08

GlaxoSmithKline And Genmab Announce Positive Top-line Results In Ofatumumab Chronic Lymphocytic Leukaemia Pivotal Study
Medical News Today 8/9/08

Enrollment in Phase IIb Clinical Trial for I-Vation(TM) TA (MK-0140) Suspended Pending Review of Study Design By Merck & Co., Inc.
Red Orbit 8/9/08

Bristol-Myers Squibb Launches Secure The Future® Technical Assistance Program To Optimize Community Services For Comprehensive HIV Management
Medical News Today 8/9/08

Warner Chilcott Q2 Profit Rises On Higher Sales, Lower Expenses, Backs FY08 Outlook
RTT News 8/9/08

Movers roundup: Par Pharma, Alkermes
CNN Money 8/9/08

Watson Pharmaceuticals Announces Limited Recall of Fentanyl Transdermal System (with correction)
Earth Times 8/9/08

Lorus Therapeutics Successfully Completes Rights Offering, Raising $3.71 Million
CNN Money 8/9/08

Sound Pharmaceuticals wins FDA approval for Phase II hearing loss study
Pharmaceutical Business Review 8/9/08

Shareholder Alert: The Rosen Law Firm Announces Investigation of Dilutive Financing of Genta Incorporated
Yahoo 8/9/08

Novavax widens loss
Bizjournals 8/9/08

Aradigm's Q2 loss grows
Triangle Business Journal 8/9/08

IntelliPharmaCeutics Provides Update on Activities
CNW Telbec , Canada 8/9/08

Cytori Therapeutics shares fall on wider 2Q loss
Yahoo/AP 8/9/08

Labopharm reports results for second quarter fiscal 2008
CNW Telbec , Canada 8/9/08

GenVec reports $6.5 million loss
Bizjournals 8/9/08

Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
MSN Money 8/9/08

BioSante Pharmaceuticals Reacquires Elestrin
Pharmpro 8/9/08

King Pharma tumbles on weak sales
Marketwatch 8/7/08

The FDA's Black Box
Forbes 8/7/08

Be Selective with Medical Device Companies
Seeking Alpha 8/7/08

GlaxoSmithKline pays $15 million to Tolerx
Bizjournals 8/7/08

GSK: Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
Yahoo 8/7/08

Rituxan may heal common kidney condition
Reuters 8/7/08

J&J Submits NDA for Anti-Coagulant Xarelto
FDA News 8/7/08

Novartis says started Fluvirin shipment to U.S.
Forbes 8/7/08

Exelixis Gets Ready to Partner Up
Motley Fool 8/7/08

Genzyme inks deal
Bizjournals.com 8/7/08

Isolagen Smiles
Forbes 8/7/08

Pfizer, Roche Cancer Drugs Rejected by U.K. Agency on Cost
Bloomberg 8/7/08

Amgen Should Start Paying a Dividend
Seeking Alpha 8/7/08

Novo Nordisk H1 profit up, outlook hits shares
Reuters 8/7/08

Lilly's $1.6 billion deal with Covance aimed at cutting R&D costs
PharmaTimes, UK 8/7/08

FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
Seeking Alpha 8/7/08

Acambis Revenue Doubles As Holders Mull Sanofi Offer
Easy Bourse 8/7/08

Barr Pharmaceuticals reports 2Q profit increase
Yahoo/AP 8/7/08

Isis narrows second-quarter loss
Marketwatch 8/7/08

Onyx in the Black -- for Now
Motley Fool 8/7/08

Illumina Grabs Some Cash
Motley Fool 8/7/08

Novartis Shares Fall the Most Since July on JPMorgan Downgrade
Bloomberg 8/6/08

Novartis to sell generic Plavix for 25 pct less
Reuters 8/6/08

Merck Asthma Drug Gets Wind Knocked Out Of It
Easy Bourse 8/6/08

Bayer takes Sandoz to court in bid to defend Yaz patents
PharmaTimes, UK 8/6/08

J&J pays up for Pfizer consumer unit error
Fierce Pharma 8/6/08

Mylan posts loss on acquisition items
Reuters 8/6/08

FDA Approves 2008-2009 Flu Vaccines
Trading Markets 8/6/08

Genentech’s New ADC Platform Has Much Potential, but Is Yet to Be Tested on Humans
Seeking Alpha 8/6/08

Status shift predicted for drug firms
Newark Star Ledger, NJ 8/6/08

Zacks Analyst Blog Highlights: Regeneron, Sanofi-Aventis S.A., AstraZeneca, Ambac Financial and Citigroup
Trading Markets 8/6/08

Eli Lilly Charmed by China High Growth Potential
Trading Markets 8/6/08

Analysts' Upgrades, Downgrades: Elan
TheStreet.com 8/6/08

Ariad Pharmaceuticals to receive $2.5 million from partner Merck for cancer drug development
Yahoo/AP 8/6/08

Adolor Turns to profit in Q2
RTT News 8/6/08

BioMarin Pharmaceuticals shares dive on Kuvan sales, Wall Street maintains positive outlook
Yahoo/AP 8/6/08

Growing Nexavar Sales Boost Onyx Q2
Bizjournals 8/6/08

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
Yahoo 8/6/08

ImClone - Bristol-Myers Merger: The Negotiations Begin
Seeking Alpha 8/5/08

Icahn Responds to BMS Offer for ImClone
Seeking Alpha 8/5/08

Daiichi Wins Approval to Buy Ranbaxy After Hurdles
Bloomberg 8/5/08

Health Winners & Losers: Elan
TheStreet.com 8/5/08

Roche tipped to be world's top drugmaker by 2014
Forbes/Reuters 8/5/08

Pfizer Tries To Bully Law Firm Into Celebrex Deal
Pharmalot 8/5/08

Wyeth gets subpoenas tied to Protonix
Yahoo/Reuters 8/5/08

Bayer sues Novartis unit over generic contraceptive
Hemscott, UK 8/5/08

Schering-Plough drug results pressure Vertex stock
IT BusinessNet 8/5/08

Increasing M&A Activity in the Generics Industry: What happens next?
OBBeC 8/5/08

SuperGen swings to Q2 loss, tightens belt
Bizjournals.com 8/5/08

NitroMed swings to profit
Bizjournals.com 8/5/08

Pharmacopeia to lay off approximately 40% of workforce
Marketwatch 8/5/08

Medicines Co. gets lift from drug approval
Star Ledger, NJ 8/5/08

Gilead anti-AIDS gel might help men too, study finds
Reuters 8/5/08

Valeant to sell certain European business operations to Meda
Pharmaceutical Business Review 8/5/08

Estrogen May Ease Schizophrenia Symptoms in Women, Study Finds
Bloomberg 8/5/08

Astellas introduces antifungal agent Mycamine in UK
Pharmaceutical Business Review 8/5/08

Pharmasset hepatitis C drug candidate meets safety goals in early-stage study
Yahoo/AP 8/5/08

ImClone To Bristol: Gimme More
Forbes 8/4/08

Lilly says $3-a-share bid for SGX is best and final offer
Marketwatch 8/4/08

What Are Your Biogen Idec Options?
SeekingAlpha 8/4/08

Schering-Plough stunned by FDA's rejection of Bridion
Pharma Times, UK 8/4/08

Novartis says FDA OKs Diovan HCT and Exforge Single-Pill Combinations as first-line treatments for high BP
RTT News 8/4/08

Verispan: Merck Advances to No. 1 with Managed Care Executives
iStockAnalyst 8/4/08

Time to Buy Elan?
Seeking Alpha 8/4/08

GlaxoSmithKline Trims Down Oncology Head Count
Seeking Alpha 8/4/08

A Second Chance to Buy Wyeth?
Barron's 8/4/08

Brain Drain For Biogen, Elan
Forbes 8/4/08

Abbott faces more litigation over AIDS drug
Yahoo/AP 8/4/08

China Biotech in Review: Company Profiles and Drug Advancement
Seeking Alpha 8/4/08

UCB's first-half net income falls on weaker Zyrtec sales
Pharma Times, UK 8/4/08

Astellas Shares Rise to 2008 High on Profit Outlook
Bloomberg 8/4/08

KV Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case Denied
Seeking Alpha 8/4/08

Marcial: Clinical Data Is a Biotech to Watch
Businessweek 8/4/08

Gilead AIDS Drugs May Hold Key to Prevent Infections
Bloomberg 8/4/08

FDA OKs Medicines Co.'s Cleviprex
TheStreet.com 8/4/08

The Technician: Healthcare ETFs Stage Recovery
Seeking Alpha 8/4/08

La Jolla Pharma 2Q loss rises on research costs
Yahoo/AP 8/4/08

Karo Bio Gains Most in 3 Years After Drug Study
Bloomberg 8/4/08

Elan Becomes a Bad News Buy
The Motley Fool 8/2/08

Bristol-Myers sells ConvaTec wound-care unit
BusinessWeek 8/2/08

Holy Moley, CV Therapeutics!
Motley Fool 8/2/08

FDA rejects Schering-Plough drug
Bizjournals 8/2/08

AstraZeneca Battling Generics
Yahoo/Zacks 8/2/08

Daiichi says terms of open offer for Ranbaxy may change
Economic Times 8/2/08

Cell Genesys Q2 loss widens on lower tax benefit
RTT 8/2/08

Oscient Pharma Posts Wider Loss In Q2; Cuts FY08 Revenue Outlook
RTT 8/2/08

Drug firms go slow on patent challenges
MSN India 8/2/08

Bristol-Myers offering $4.5 billion for ImClone
Yahoo/AP 7/31/08

FDA: More Label Warnings for Anemia Drugs
TheStreet.com 7/31/08

Sanofi Profit Falls as Top-Selling Drugs Miss Analyst Estimates
Bloomberg 7/31/08

Lilly Trained Sales Force to Ignore Drug's Risks, Documents Say
Bloomberg 7/31/08

AstraZeneca ups outlook after 14% profit rise
Marketwatch 7/31/08

J&J, Bayer seek FDA approval for anticlotting drug
Yahoo/AP 7/31/08

Takeda Raises Profit Forecast on Millennium Purchase
Bloomberg 7/31/08

Eisai Profit Falls 14% on MGI Pharma Acquisition Cost
Bloomberg 7/31/08

Baxter boosted by drug's head start: Alzheimer's candidate used for other diseases
Trading Markets 7/31/08

[video]Medivation unveils positive test results for its Alzheimer's drug
CNBC 7/31/08

Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Yahoo 7/31/08

Teva Has Revenue in All the Wrong Places
Motley Fool 7/31/08

Glaxo says therapeutic vaccines hold big promise
Reuters, UK 7/31/08

Longer-Acting Relenza Fights Flu as Well as Tamiflu
Bloomberg 7/31/08

Baxter boosted by drug's head start: Alzheimer's candidate used for other diseases
Trading Markets 7/31/08

Endo Pharma Q2 profit tops Street, backs '08 view
Reuters, UK 7/31/08

Abbott agrees to pay as much as $27.5M to settle AIDS patients' antitrust lawsuit
Yahoo/AP 7/31/08

Elan, Wyeth tumble on Alzheimer's study
Marketwatch 7/31/08

Roche files MabThera for leukaemia treatment in EU
Reuters, UK 7/31/08

Generic drug backlog to spike: FDA official
Reuters 7/31/08

Hey, Drug Researchers, Lotsa Luck!
WSJ Online 7/31/08

Genta Tempered by Trial Costs
Yahoo/Zacks.com 7/31/08

Quark, Pfizer start Phase II dosing
MSN Money 7/31/08

Drug Marketing Poised For Historic Decline
Brandweek 7/30/08

Alzheimer's Drug Showdown
Forbes 7/30/08

US approves generics of Abbott seizure drug
Reuters, UK 7/30/08

Eli Lilly with Pipeline Issues
Yahoo/Zacks.com 7/30/08

Earnings Preview: Allergan
SeekingAlpha 7/30/08

Avoid Value Traps Like Merck and Pfizer
TheStreet.com 7/30/08

Novartis's bone drug recommended for treatment of osteoporosis in men
Trading Markets 7/30/08

Time for Biotech? - Fast Money Recap
SeekingAlpha 7/30/08

Marcial: Drugmaker Pfizer, a 'Fallen Angel?'
Businessweek 7/30/08

Boring is good at Teva
Globes, Israel 7/30/08

Bayer 2Q net profit slips 13 percent
IHT 7/30/08

Pozen: Migraine pill's success hinges on FDA
Trading Markets 7/30/08

Elan Corp.: Bounce on Goldman Positivity?
SeekingAlpha 7/30/08

Cephalon Beats Profit Targets
TheStreet.com 7/30/08

Biotech Bucks the Market Trend
SeekingAlpha 7/30/08

Buzzkill For Sepracor
Forbes 7/30/08

Health Winners & Losers: Amgen
TheStreet.com 7/30/08

Amgen, Alexion Pharmaceuticals Surge On Healthy Earnings, Positive Drug Trial
Investor's Business Daily 7/30/08

Vanda's Schizophrenia Drug Goes Down for the Last Time
SeekingAlpha 7/30/08

GenVec wins funding for foot-and-mouth vaccine program
Bizjournals.com 7/30/08

Mylan buys out Watson’s interest in Somerset Pharmaceuticals
Bizjournals.com 7/30/08

Alexion Pharmaceuticals shares hit new high on swing to 2Q profit, outlook for key drug sales
Yahoo/AP 7/30/08

Novo Nordisk employee charged with insider trading
Yahoo/AP 7/30/08

Cohen's SAC Boosts Stake in Invitrogen to 6.9%
SeekingAlpha 7/30/08

Amgen Posts Profit Beat
TheStreet.com 7/29/08

Study: Novartis' blood pressure drug Exforge outperforms Norvasc
StarLedger, NJ 7/29/08

Pfizer Wins Dismissal of Price-Fixing Lawsuit by Drugstores
Bloomberg 7/29/08

Sepracor 2nd-qtr profit jumps on tax benefit, falls short of Street view; revenue outlook cut
Yahoo/AP 7/29/08

Abbott Laboratories: The Choice Within Big Pharma
SeekingAlpha 7/29/08

I Still Like Amgen - Despite the Recent Run-up
SeekingAlpha 7/29/08

Biotech: New Hottie of the Market
iStockAnalyst 7/29/08

GlaxoSmithKline payment boosts Pozen earnings
Bizjournals.com 7/29/08

Amgen's D-mab Delights Investors
Seeking Alpha 7/29/08

Teva Getting Even More Generic, Coach Plans to Be Big in China
BarronsOnline 7/29/08

Sales breaches cost Pfizer, Roche, Glaxo
Fierce Pharma 7/29/08

Takeda May Post First Loss in 23 Years on Acquisition
Bloomberg 7/29/08

SciClone narrows Q2 loss on hepatitis drug sales
Bizjournals.com 7/29/08

Alcon Trades at Lofty Valuation
Yahoo/Zacks.com 7/29/08

Japan ripe for generics, says Teva chief
FT.com 7/29/08

Vanda shares plunge on FDA drug rejection
Yahoo/AP 7/29/08

Barr, Amgen enter drug patent dispute
Yahoo/AP 7/29/08

Alexion swings to profit as Soliris sales rise
Marketwatch 7/29/08

Inspire extends study of cystic fibrosis drug
Bizjournals.com 7/29/08

Wake-Up Call For Minrad
Forbes 7/29/08

BioCryst shares rise as flu drug hits study goal
Yahoo/AP 7/29/08

Sanofi to buy UK vaccine maker Acambis
Forbes 7/28/08

Big Pharma self-medicates in a bid to lift ailing returns
Guardian, UK 7/28/08

Pfizer's Kindler Says He Inherited Inefficient Research Effort
Bloomberg 7/28/08

Roche faces obstacles in acquiring Genentech
InPharmaTechnologist 7/28/08

Amgen higher after progress on osteoporosis drug
Marketwatch 7/28/08

Elan, Wyeth to report midstage data on key Alzheimer's disease treatment candidate
Yahoo/AP 7/28/08

Pfizer’s Kindler Decries His ‘Monolithic Structure’
Pharmalot 7/28/08

Novartis' Exforge more effective than only amlodipine
Reuters, UK 7/28/08

A Biotech Bloom in July
Seeking Alpha 7/28/08

Boning Up on Amgen’s Rally
WSJ Online 7/28/08

Glaxo's Stem-Cell Bet
Forbes 7/28/08

Pfizer CEO: R&D Needs To Be More Efficient
WSJ Online 7/28/08

The Implications of Health-Care Reform
Businessweek 7/28/08

Another Disappointing Year for Alzheimer’s Drugs
WSJ Online 7/28/08

Vanda Pharma Sinks on FDA Rejection
TheStreet.com 7/28/08

Exelixis hopes for Glaxo licensing payment
Forbes 7/28/08

Swiss biotech Addex makes first profit,shares rise
Hemscott, UK 7/28/08

Chugai Shares Rise After FDA Says Actemra Drug Works
Bloomberg 7/28/08

Nexavar Approved for Liver Cancer in China
Yahoo 7/28/08

Drug Test a Success for Amgen
The Ledger, FL 7/27/08

Summer Slump for China Biotech News
Seeking Alpha 7/27/08

The State of Statins and Stents
Seeking Alpha 7/27/08

Dr Reddy’s Laboratories: Hold
Sify, India 7/27/08

FDA Rejection Likely for Biovest
Minyanville 7/27/08

Bristol/Lilly: The Battle Begins
Forbes 7/25/08

Buyout or Sellout (Teva/Barr and Roche/Genentech)?
Motley Fool 7/25/08

Will Pfizer Pfizzle?
Motley Fool 7/25/08

Roche's Big Hurdle with Genentech
Businessweek 7/25/08